Analyst Price Target is $50.42
▼ -9.89% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for Health Catalyst in the last 3 months. The average price target is $50.42, with a high forecast of $66.00 and a low forecast of $37.00. The average price target represents a -9.89% upside from the last price of $55.95.
Current Consensus is
The current consensus among 10 polled investment analysts is to buy stock in Health Catalyst.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.